will insurance cover a glp 1 If you’ve been told by your primary care doctor that your plan not GLP-1… , let me try! 😉, DM me to learn more. , ., ., ., #medicalweightloss #weightloss #weightlossprogram Will Cigna Cover Ozempic®, Wegovy®,

Nayan Patel: So, the serums, yes you do

Regulatory debates continue on whether stricter guidelines should be enforced to ensure patient safety without stifling access to necessary medications

Pair with movement: Focus on resistance training and regular aerobic activity to enhance metabolic rate and preserve muscle

IGF1-LR3 Longevity Research IGF1 LR3 promotes tissue repair and maintenance throughout the body, making it a protective molecule against cell damage and the effects of aging

Cagrilintide development and structure What cagrilintide is: Synthetic long-acting amylin analog Modified 37-amino acid sequence Developed by Novo Nordisk Designed specifically for obesity treatment Based on natural amylin but optimized Key structural modifications: Amino acid substitutions for stability Prevented amyloid aggregation (major improvement) Extended half-life to ~7 days (vs minutes for natural amylin) Maintained receptor binding and activity Better pharmacokinetic profile Development timeline: Early 2010s: Initial development 2019-2020: Phase 2 trials (OASIS) 2021-2023: Phase 3 trials (REDEFINE as CagriSema) 2024-2025: FDA submission expected Likely approval 2025-2026 Why cagrilintide is breakthrough: First truly long-acting amylin agonist Weekly dosing (vs pramlintide 2-3x daily) Designed for weight loss (not diabetes adaptation) Proven synergy with semaglutide (CagriSema) Approaching availability Cagrilintide weight loss results Monotherapy clinical data (OASIS trials): Duration: 26-68 weeks Dose: 2.4mg weekly (standard) Average weight loss: 10-12% Some participants: 15%+ loss Well-tolerated at therapeutic dose Weight loss by dose: 0.6mg weekly: ~6% weight loss 1.2mg weekly: ~8% weight loss 2.4mg weekly: ~10% weight loss 4.5mg weekly: ~12% weight loss (higher side effects) CagriSema combination (cagrilintide + semaglutide): Both at 2.4mg weekly Average weight loss: 15.6% (REDEFINE-1) Excellent responders: 20-25% 50% more than semaglutide alone Game-changing results Real-world expectations: See our comprehensive cagrilintide weight loss guide

Complete all required account set up fields to ensure accurate CE reporting